Private Market View

AgomAb

Drug Discovery · Antwerp, Belgium · Founded 2017 · Privately Held (backing)

Last price · $/share
Implied valuation
$415.6M
Total raised
$334.0M
Last round
Later Stage VC (Series C)
Oct 2023
What is AgomAb worth?
$415.6Mlast known valuation

AgomAb last raised $100.7M in its Later Stage VC (Series C) (Oct 2023).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 1 rounds
  • ·The complete investor list — 17 names
  • ·Watchlist + deal alerts for AgomAb
Create free account
No card required

Funding history

1 rounds
DateRoundRaisedPost-money
Oct 2023Later Stage VC (Series C)$100.7M

How AgomAb's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For AgomAb, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is AgomAb worth?
AgomAb's last known valuation is $415.6M.
How much has AgomAb raised?
AgomAb has raised $334.0M in total funding across 1 recorded rounds.
When did AgomAb last raise?
AgomAb last raised in Oct 2023 (Later Stage VC (Series C)), raising $100.7M.